These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 11348476)

  • 1. The effect of methoxsalen dose on ultraviolet-A-induced erythema.
    Ibbotson SH; Dawe RS; Farr PM
    J Invest Dermatol; 2001 May; 116(5):813-5. PubMed ID: 11348476
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the dose-response relationship for psoralen-UVA erythema and UVB erythema.
    Cox NH; Farr PM; Diffey BL
    Arch Dermatol; 1989 Dec; 125(12):1653-7. PubMed ID: 2589859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between plasma psoralen concentration and psoralen-UVA erythema.
    Mclelland J; Fisher C; Farr PM; Diffey BL; Cox NH
    Br J Dermatol; 1991 Jun; 124(6):585-90. PubMed ID: 2064944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The time-course of psoralen ultraviolet A (PUVA) erythema.
    Ibbotson SH; Farr PM
    J Invest Dermatol; 1999 Sep; 113(3):346-50. PubMed ID: 10469332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phototoxicity of new psoralen-containing gels and creams versus bath PUVA.
    Nimkulrat P; Leenutaphong V; Sudtim S
    J Med Assoc Thai; 2005 Oct; 88(10):1406-11. PubMed ID: 16519387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment.
    Tanew A; Kipfelsperger T; Seeber A; Radakovic-Fijan S; Hönigsmann H
    J Am Acad Dermatol; 2001 Apr; 44(4):638-42. PubMed ID: 11260539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PUVA erythemal sensitivity depends on plasma psoralen concentration and UVA sensitivity.
    Sakuntabhai A; Farr PM; Diffey BL
    Br J Dermatol; 1993 May; 128(5):561-5. PubMed ID: 8504050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dietary intake and risk assessment of phototoxic furocoumarins in humans.
    Schlatter J; Zimmerli B; Dick R; Panizzon R; Schlatter C
    Food Chem Toxicol; 1991 Aug; 29(8):523-30. PubMed ID: 1894218
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The time course of topical PUVA erythema following 15- and 5-minute methoxsalen immersion.
    Man I; Kwok YK; Dawe RS; Ferguson J; Ibbotson SH
    Arch Dermatol; 2003 Mar; 139(3):331-4. PubMed ID: 12622625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsoriatic, erythematogenic, and Langerhans cell marker depleting effect of bath-psoralens plus ultraviolet A treatment. Comparison of 8-methoxypsoralen and trimethylpsoralen photosensitization.
    Koulu LM; Jansén CT
    J Am Acad Dermatol; 1988 May; 18(5 Pt 1):1053-9. PubMed ID: 2968374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erythema action spectrum of topical 8-methoxypsoralen-sensitized skin re-evaluated: implications for routine clinical practice.
    Al-Ismail D; Edwards C; Anstey AV
    Br J Dermatol; 2016 Jan; 174(1):131-5. PubMed ID: 26383592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Skin pigmentation as a predictor of minimal phototoxic dose after oral methoxsalen.
    Bech-Thomsen N; Angelo HR; Wulf HC
    Arch Dermatol; 1994 Apr; 130(4):464-8. PubMed ID: 8166483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of photosensitivity in bath-PUVA photochemotherapy.
    Gruss C; Behrens S; Reuther T; Husebo L; Neumann N; Altmeyer P; Lehmann P; Kerscher M
    J Am Acad Dermatol; 1998 Sep; 39(3):443-6. PubMed ID: 9738780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
    Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
    J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen.
    Lowe NJ; Weingarten D; Bourget T; Moy LS
    J Am Acad Dermatol; 1986 May; 14(5 Pt 1):754-60. PubMed ID: 3711379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of bioavailability and phototoxicity of two oral preparations of 5-methoxypsoralen.
    Stolk LM; Siddiqui AH; Westerhof W; Cormane RH
    Br J Dermatol; 1985 Apr; 112(4):469-73. PubMed ID: 3994922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A polychromatic action spectrum for photosensitivity to orally administered 8-methoxypsoralen in humans.
    Bech-Thomsen N; Wulf HC
    Clin Exp Dermatol; 1994 Jan; 19(1):12-5. PubMed ID: 8313631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction in 8-methoxypsoralen immersion time alters the erythemal response to bath PUVA.
    Azurdia RM; Dean MP; Rhodes LE
    Photodermatol Photoimmunol Photomed; 2000 Aug; 16(4):186-8. PubMed ID: 11019945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-response relations in phototoxicity due to 8-methoxypsoralen and UV-A in man.
    Ljunggren B; Bjellerup M; Carter DM
    J Invest Dermatol; 1981 Feb; 76(2):73-5. PubMed ID: 7462679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psoralen-ultraviolet A-induced erythema: sensitivity correlates with the concentrations of psoralen in suction blister fluid.
    Yeo UC; Shin JH; Yang JM; Park KB; Kim MM; Bok HS; Lee ES
    Br J Dermatol; 2000 Apr; 142(4):733-9. PubMed ID: 10792224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.